Cited by 37Seaweed-derived Bioactive CompoundsPeroxisome Proliferator-Activated ReceptorsPharmacology and Obesity Treatment

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Inhibition of Adipogenesis by Diphlorethohydroxycarmalol (DPHC) through AMPK Activation in Adipocytes

Open access

Abstract

The purpose of this study was to investigate the antiobesity effect and the mechanism of action of diphlorethohydroxycarmalol (DPHC) isolated from Ishige okamurae in 3T3-L1 cells. The antiobesity effects were examined by evaluating intracellular fat accumulation in Oil Red O-stained adipocytes. Based on the results, DPHC dose-dependently inhibited the lipid accumulation in 3T3-L1 adipocytes. DPHC significantly inhibited adipocyte-specific proteins such as SREBP-1c, PPARγ, C/EBP α, and adiponectin, as well as adipogenic enzymes, including perilipin, FAS, FABP4, and leptin in adipocytes. These results indicated that DPHC primarily acts by regulating adipogenic-specific proteins through inhibiting fat accumulation and fatty acid synthesis in adipocytes. DPHC treatment significantly increased both AMPK and ACC phosphorylation in adipocytes. These results indicate that DPHC inhibits the fat accumulation by activating AMPK and ACC in 3T3-L1 cells. Taken together, these results suggest that DPHC can be used as a potential therapeutic agent against obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md17010044

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adipocytes play a vital role in the regulation of energy intake, energy expenditure, and both lipid and carbohydrate metabolism; lowering lipogenesis, enhancing lipolysis, and decreasing pre-adipocyte differentiation are strategies against obesity.

    “Adipocytes play a vital role in the regulation of energy intake, energy expenditure, and both lipid and carbohydrate metabolism; thus, they lower lipogenesis, enhance lipolysis, and decrease pre-adipocyte differentiation, all of which are strategies against obesity [14,15,19].”
  • Obesity is influenced by numerous factors, such as energy balance, biological factors, and hormones/cytokines/other factors.

    “Evidences showed obesity is influenced by numerous factors, such as the energy balance, biological factors, and hormones/cytokines/other factors [15,16].”
  • PPARγ, C/EBPα, and SREBP-1c are important regulators of adipogenesis.

    “In mammalian cells, the peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding protein α (C/EBPα), and sterol regulatory element-binding protein 1c (SREBP-1c) [15] are known to act as important regulators of adipogenesis.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Kang, M.-C., Ding, Y., Kim, H.-S., Jeon, Y.-J., & Lee, S.-H.
Affiliations
  • Korea Food Research Institute (KR)
  • Soonchunhyang University (KR)
  • Jeju National University (KR)
Corresponding author
Lee, Seung-Hong
Venue
Marine Drugs
Publisher
MDPI AG
Published
2019-01-10
Volume
17
Issue
1
Pages
44
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2909539549
Cited by
37
References
32
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 10
FWCI
5.79
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
adipogenesis inhibition, AMPK activation, 3T3-L1 adipocytes, lipid accumulation, fatty acid synthesis, SREBP-1c, PPARγ, adiponectin, acetyl-CoA carboxylase, anti-obesity, marine natural products
MeSH terms
Adenylate Kinase, Animals, Cell Survival, Heterocyclic Compounds, 3-Ring, Seaweed, Molecular Structure, Gene Expression Regulation, Enzymologic, Adipocytes, 3T3-L1 Cells, Adipogenesis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review